The Role of Epigenetics in Myocardial Infarction: Mechanism and Therapeutic Potential
Open Access
- 11 September 2024
- journal article
- review article
- Published by Salvia Medical Sciences Ltd in Galen Medical Journal
- Vol. 13, e3474
Abstract
Myocardial infarction (MI), remains one of the leading causes of morbidity and mortality worldwide. As a result, understanding the underlying mechanisms of MI is crucial for developing effective therapeutic strategies. Epigenetics, which involves heritable changes in gene expression without altering the underlying DNA sequence, has emerged as a significant factor in the pathogenesis and progression of MI. Key epigenetic mechanisms such as DNA methylation, histone modifications, and noncoding RNAs (ncRNAs) have been shown to regulate genes associated with inflammation, apoptosis, fibrosis, and cardiac repair. These epigenetic alterations contribute to the complex gene-environment interactions that influence clinical outcomes in MI patients. Recent research has identified specific epigenetic changes that can serve as biomarkers for MI risk stratification, offering potential for early diagnosis and personalized therapeutic interventions. Moreover, targeting these epigenetic modifications holds promise as a therapeutic strategy to reduce myocardial damage, enhance cardiac function, and prevent adverse remodeling after MI. This review explores the mechanisms by which epigenetic regulation influences MI pathogenesis and discusses the therapeutic potential of targeting these pathways to improve patient outcomes. By integrating epigenetic therapies into clinical practice, it may be possible to revolutionize the treatment of MI, addressing the disease at its molecular roots and offering more effective, durable interventions.Keywords
This publication has 91 references indexed in Scilit:
- Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with AtherosclerosisMolecular Diagnosis & Therapy, 2023
- Histone modification landscape and the key significance of H3K27me3 in myocardial ischaemia/reperfusion injuryScience China Life Sciences, 2023
- LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathwayBasic Research in Cardiology, 2021
- Therapeutic effects of histone deacetylase inhibitors on heart diseaseArchives of Pharmacal Research, 2020
- The Long Non-coding Road to AtherosclerosisCurrent Atherosclerosis Reports, 2020
- Lnc-Ang362 is a pro-fibrotic long non-coding RNA promoting cardiac fibrosis after myocardial infarction by suppressing Smad7Archives of Biochemistry and Biophysics, 2020
- Exosomal miRNAs as potential biomarkers for acute myocardial infarctionIUBMB Life, 2019
- Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarctionAtherosclerosis, 2018
- miRNA-1 and miRNA-133a are involved in early commitment of pluripotent stem cells and demonstrate antagonistic roles in the regulation of cardiac differentiationJournal of Tissue Engineering and Regenerative Medicine, 2014
- Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac LineageCell, 2012